https://lomeguatribinhibitor.c....om/weight-problems-a
The secondary endpoint assessment considers the number of dose alterations, the time required to attain the initially determined trough level, and the incidence of graft rejection cases. Subsequently, clinical and laboratory parameters will be examined over a period of three years. The C/D ratio serves as an approximation of tacrolimus's bioavailability. By
Like
Comment
Share
